New Leaf BPO Associates II, L.P. — SEC Form 4 filings

SEC reporting owner CIK 1740783. 1 Form 4 filing on record with FilingPulse; latest filed 2024-03-11.

Transaction summary — filings shown

Covers all 1 filing on record, filed 2024-03-11 to 2024-03-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Harpoon Therapeutics, Inc. (HARP)Director, 10% owner16

Form 4 filings — New Leaf BPO Associates II, L.P.

FiledFormIssuerReported transactionsSource
2024-03-114Harpoon Therapeutics, Inc. (HARP)
jointly with New Leaf Biopharma Opportunities II, L.P., New Leaf Ventures III, L.P., New Leaf Venture Associates III, L.P., New Leaf Venture Management III, L.L.C., New Leaf BPO Management II, L.L.C, Lathi Vijay K
Disposition to issuer (D): 1,463,386 · Disposition to issuer (D): 395,783 · Disposition to issuer (D): 10,000 · Disposition to issuer (D): 299,430 (derivative) · Disposition to issuer (D): 686,000 (derivative) · Disposition to issuer (D): 85,750 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1740783 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →